Mielopatía e infección por el virus de la inmunodeficiencia humana

Medicina Clinica

Volumn 112, Issue 11, 1999, Pages 423-427

  Lleó, Alberto ^b   Planella, Montserrat ^b   Domingo, Pere ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS RELATED COMPLEX; CRYPTOCOCCOSIS; CYTOMEGALIC INCLUSION BODY DISEASE; FEMALE; HERPES VIRUS INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; LEUKOENCEPHALOPATHY; MALE; MYELITIS; NEWBORN; REVIEW; SPINAL CORD DISEASE; SYPHILIS; TOXOPLASMOSIS; TUBERCULOUS SPONDYLITIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS INFECTIONS; DELTARETROVIRUS INFECTIONS; FEMALE; HERPESVIRIDAE INFECTIONS; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; MYELITIS; MYELITIS, TRANSVERSE; SPINAL CORD DISEASES; SYPHILIS; TOXOPLASMOSIS; TUBERCULOSIS, SPINAL;

EID: 0033608594     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Snider WD, Simpson DM, Nielsen S, Gold JW, Metroka E, Posner JB. Neurological complications of acquired immunodeficiency syndrome: analysis of 50 patients. Ann Neurol 1983; 14: 403-418.
2. Johnson RT, McArthur JC. Myelopathies and retroviral infections. Ann Neurol 1987; 21: 113-116.
3. c ed.). Filadelfia: Lippincott-Raven, 1997; 173-187.
4. Wright EJ, Brew BJ, Currie JN, McArthur JC. HIV-induced neurological disease. Med J Aust 1996; 164:414-417.
5. Simpson DM, Bender AN. Human immunodeficiency virus-associated myopathy: analysis of 11 patients. Ann Neurol 1988; 24: 79-84.
6. Price RW. Neurological complications of HIV infection. Lancet 1996; 348: 445-452.
7. Iranzo A, Kulisevsky J, Cadafalch J, Serrano C, Grau JM. Trastornos del movimiento asociados al sida. Neurología 1996; 11: 70-74.
8. Goldstick L, Mandybur TI, Bode R. Spinal cord degeneration in AIDS. Neurology 1985; 35: 103-106.
9. Tan SV, Guiloff RJ, Scaravilli F. AIDS-associated vacuolar myelopathy: a morphometric study. Brain 1995; 118: 1.247-1.261.
10. Henin D, Smith TW, De Girolami U, Sughayer M, Hauw JJ Neuropathology of the spinal cord in the acquired immunodeficiency syndrome. Hum Pathol 1992; 23: 1.106-1.114.
11. Bergmann M, Gullota F, Kuchelmeister K, Masini T, Angeli G. AIDS-myelopathy. A neuropathological study. Pathol Res Pract 1993; 189: 58-65.
12. Artigas J, Grosse G, Niedobitek F. Vacuolar myelopathy in AIDS: a morphological analysis. Pathol Res Pract 1990; 186: 228-237.
13. Petito CK, Navia BA, Cho ES, Jordan BD, George DC, Price RW. Vacuolar myelopathy resembling subacute combined degeneration in patients with acquired immunodeficiency syndrome. N Engl J Med 1985; 312: 874-879.
14. Rosemblum M, Scheck AC, Cronin K, Brew BJ, Khan A, Paul A et al. Dissociation of AIDS-related vacuolar myelopathy and productive HIV-1 infection of the spinal cord. Neurology 1989; 39: 892-896.
15. Singh BM, Levine S, Yarrish RL, Hyland MJ, Jeanty D, Wormser GP. Spinal cord syndromes in the acquired immune deficiency syndrome. Acta Neurol Scand 1986; 73: 590-598.
16. Brew BJ, Hardy W, Zuckerman E, Chien N, Paul M, Rosemblum M. AIDS-related vacuolar myelopathy is not associated with coinfection by human T-limphotropic virus type I. Ann Neurol 1989; 26: 679-681.
17. Dickson DW, Belman AL, Kim TS, Horoupian DS, Rubinstein A. Spinal cord pathology in pediatric acquired immunodeficiency syndrome. Neurology 1989; 39: 227-235.
18. Budka H, Maier H, Pohl P. Human immunodeficiency virus in vacuolar myelopathy of the acquired immunodeficiency syndrome. N Engl J Med 1988; 319: 1.667-1.668.
19. Ho DD, Rota TR, Schooley RT. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 1985; 313: 1.493-1.497.
20. Tyor WR, Glass JD, Baumrind N, McArthur JC, Griffin JW, Becker PS et al. Cytokine expression of macrophages in HIV-1 associated vacuolar myelopathy. Neurology 1993; 43: 1.002-1.009.
21. Fuchs D, Murr C, Reibnegger G, Wachter H. HIV myelopathy. Neurology 1994; 44: 578-579.
22. Dal Pan CJ, Glass JD, McArthur JC. Clinicopathologic correlations of HIV-1-associated vacuolar myelopathy. Neurology 1994; 44: 2.159-2.164.
23. Honig LS, Vogel H, Horoupian DS. Chronic myelopathy as a presenting syndrome in HIV infection. Neurology 1989; 39 (Supl 1): 419.
24. Dal Pan GJ, Glass JD, Zeidman S, McArthur JC. Atypical HIV-associated myelopathy: diagnosis by cord biopsy. Neurology 1992; 42 (Supl 3): 257.
25. a ed.). Filadelfia: WB Saunders Company, 1997; 197-216.
26. Mehren M, Burns PJ, Mamani F, Levy CS, Laureno R. Toxoplasmic myelitis mimicking intramedullary spinal cord tumor. Neurology 1988; 38: 1.648-1.649.
27. Herskovitz S, Siegel SE, Schneider AT, Nelson SJ, Goodrich JT, Lantos G. Spinal cord toxoplasmosis in AIDS. Neurology 1989; 30: 1.552-1.553.
28. Overhage JM, Greist A, Brown DR. Conus medullaris syndrome resulting from Toxoplasma gondii infection in a patient with the acquired immunodeficiency syndrome. Am J Med 1990; 89: 814-815.
29. Vyas R, Ebright JR. Toxoplasmosis of the spinal cord in a patient with AIDS: case report and review. Clin Infect Dis 1996; 23: 1.061-1.065.
30. Ferrer S, Fuentes I, Domingo P, Muñoz C, Iranzo A, Barrio JL et al. Toxoplasmosis encefálica en pacientes con infección por el virus de la inmunodeficiencia humana (VIH). An Med Intern (Madrid) 1996; 13: 4-8.
31. Arribas JR, Storch GA, Clifford DB, Tselis AC. Cytomegalovirus encephalitis. Ann Intern Med 1996; 125: 577-587
32. Fuller GN, Gill SK, Guiloff RJ, Kapoor R, Lucas SB, Sinclair E et al. Ganciclovir for lumbosacral polyradiculopathy in AIDS. Lancet 1990; 335: 48-49.
33. Cohen BA, McArthur JC, Grohman S, Patterson B, Glass JD. Neurologic prognosis of cytomegalovirus polyradiculopathy in AIDS. Neurology 1993; 43: 493-499.
34. Eidelberg D, Sotrel A, Vogel H, Walker P, Kleefield J, Crumpacker CS. Progressive polyradiculopathy in acquired immune deficiency syndrome. Neurology 1986; 36: 912-916.
35. Behar R, Wiley C, McCutchan JA. Cytomegalovirus polyradiculoneuropathy in acquired immune deficiency syndrome. Neurology 1987; 37: 557-561.
36. Graveleau Ph, Perol R, Chapman A. Regression of cauda equina syndrome in AIDS patient being treated with ganciclovir. Lancet 1989; 2: 511-512.
37. Bazan III C, Jackson J, Jinkins JR, Barohn RJ. Gadolinium-enhanced MRI in a case of cytomegalovirus polyradiculopathy. Neurology 1991; 41: 1.522-1.523.
38. Mahieux F, Gray F, Fenelon G, Gherardi R, Adams D, Guillard A et al. Acute myeloradiculitis due to cytomegalovirus as the initial manifestation of AIDS. J Neurol Neurosurg Psychiatry 1989; 52: 270-274.
39. Tucker T, Dix RD, Katzen C, Davis RL, Schmidley JW. Cytomegalovirus and herpes simplex virus ascending myelitis in a patient with acquired immune deficiency syndrome. Ann Neurol 1985; 18: 74-79.
40. Granter SR, Doolittle MH, Renshaw AA. Predominance of neutrophils in the cerebrospinal fluid of AIDS patients with cytomegalovirus radiculopathy. Clin Microbiol Infect Dis 1996; 105: 364-366.
41. Miller RG, Storey JR, Greco CM. Ganciclovir in the treatment of progressive AIDS-related polyradiculopathy. Neurology 1990; 40: 569-574.
42. Miró O, Miranda-Guardiola F, Graus F, Miró JM. Alteraciones neurorradiológicas en un caso de polirradiculopatía lumbosacra por citomegalovirus en un enfermo de sida. Rev Clin Esp 1995; 195: 442-443.
43. Naguib TM, Lastrapes DL, Brandon FM, Wilson DA, Brumback RA, Greenfield RA. Spinal subarachnoid mass and polyrradiculopathy due to cytomegalovirus in a patient with AIDS. Clin Infect Dis 1995; 20: 1.434-1.435.
44. Kim YS, Hollander H. Polyradiculopathy due to cytomegalovirus: report of two cases in wich improvement occurred after prolonged therapy and review of the literature. Clin Infect Dis 1993; 17: 32-37.
45. Domingo P, Puig M, Iranzo A, López-Contreras J, Ris J. Polyradiculopathy due to cytomegalovirus infection: report of a case in wich and AIDS patient responded to foscarnet therapy. Clin Infect Dis 1994; 18. 1.019-1.020.
46. Decker CF, Tarver III JH, Murray DF, Martin GJ. Prolonged concurrent use of ganciclovir and foscarnet in the treatment of polyradiculopathy due to cytomegalovirus in a patient with AIDS. Clin Infect Dis 1994; 19: 548-549.
47. Britton CB, Mesa-Tejada R, Fenoglio CM, Hays AP, Garvey GG, Miller JR. A new complication of AIDS: thoracic myelitis caused by herpes simplex virus. Neurology 1985, 35: 1.071-1.074.
48. Wiley CA, VanPatten PD, Carpenter PM, Powell HC, Thal LJ. Acute ascending necrotizing myelopathy caused by herpes simplex virus type 2. Neurology 1987; 37: 1.791-1.794.
49. Devinsky O, Cho E, Petito CK, Price RW. Herpes zoster myelitis. Brain 1991; 114: 1.181-1.196.
50. Whitley RJ, Gnann JW. Herpes zoster in patients with human immunodeficiency virus infection-an ever-expanding spectrum of disease. Clin Infect Dis 1995; 21:989-990.
51. Meenken C, Van den Horn GJ, Danner SA. Ocular and neurological complications of varicella zoster virus infection in a patient with AIDS. AIDS 1996; 10: 1.174-1.175.
52. Chrétien F, Gray F, Lescs C, Geny C, Dubreuil-Lemaire ML, Ricolfi F et al. Acute varicella-zoster virus vetriculitis and meningo-myelo-radiculitis in acquired immunodeficiency syndrome. Acta Neuropathol (Berl) 1993; 86: 659-665.
53. Meylan PRA, Miklossy J, Iten A, Petignat C, Meuli R, Zufferey J et al. Myelitis due to varicella-zoster virus in an immunocompromised patient without a cutaneous rash. Clin Infect Dis 1995; 20: 206-208.
54. Gómez-Tortosa E, Gadea I, Gegúndez MI, Esteban A, Rábano J, Fernández-Guerrero ML et al. Development of myelopathy before herpes zoster rash in a patient with AIDS. Clin Infect Dis 1994; 18: 810-812.
55. Manian FA, Kindred M, Fulling KH. Chronic varicella-zoster virus myelitis without cutaneous eruption in a patient with AIDS: report of a fatal case Clin Infect Dis 1995; 21: 986-988.
56. Zoguereh DD, Saadoun R, Zandotti C, Cawston P, Moreau J. AIDS-related varicella-zoster meningoencephalitis abd radicular pain without cutaneous eruption. AIDS 1996; 10: 1.604-1.606.
57. Vallejo A, Soriano V. El virus Iinfotrópico humano de tipo I (HTLV-I). Med Clin (Barc) 1995; 104: 426-435.
58. Soriano V, Gutiérrez M, Vallejo A, Aguilera A, Calderón E, Franco E et al. Infección por HTLV-I en España. Análisis de 24 casos identificados hasta noviembre de 1994. Med Clin (Barc) 1995; 105: 246-250.
59. Rosemblum M, Brew BJ, Hahn F, Shaw G, Haase A, Maroushek S et al. Human T-lymphotropic virus type l-associated myelopathy in patients with the acquired immunodeficiency syndrome. Hum Pathol 1992; 23: 513-519.
60. McArthur JC, Griffin JW, Cornblath DR, Griffin DE, Tesoriero T, Kuncl R et al. Steroid-responsive myeloneuropathy in a man dually infected with HIV-1 and HTLV-I. Neurology 1990, 40:938-944.
61. McArthur JC, Griffin JW, Cornblath DR, Farzadegan H, Tesoriero T, Gibbs CJ. Progressive HTLV-l-associated myeloneuropathy in a patient co-infected with HIV-1. Neurology 1989, 39 (Supl 1): 419.
62. Itoyama Y, Minato S, Goto I, Okochi K, Yamamoto N. Elevated serum antibody titers to Epstein-barr virus in HTLV-l-associated myelopathy (HAM). Neurology 1988; 38: 1.650-1.653.
63. Berger JR, Raffanti S, Svenningsson A, McCarthy M, Snodgrass S, Resnick L The role of HTLV in HIV-1 neurologic disease. Neurology 1991; 41:197-202.
64. Vernant JC, Maurs L, Gessain A, Barin F, Gout O, Delaporte JM et al. Endemic tropical spastic paraparesia associated with human T-lymphotropic virus type I: a clinical and serpepidemiological study of 25 cases. Ann Neurol 1987; 21: 123-130.
65. Yamasaki K, Kira J, Koyanagi Y, Kawano Y, Miyano-Kurosaki N, Nakamura M et al. Long-term, high dose inteferon-alpha treatment in HTLV-I-associated myelopathy/tropical spastic paraparesis: a combined clinical, virplogical and immunological study. J Neurol Sci 1997; 147: 135-144.
66. Harrington WJ, Sheramata W, Cabral L. Danazol for urinary incontinence in tropical spastic paraparesis. Lancet 1992; 339: 368.
67. Soriano V, Gutiérrez M. Vallejo A, Tuset C, Dronda F, Pujo E et al. Infección por el HTLV-II en España. Análisis de 113 casos hasta noviembre de 1994. Med Clin (Barc) 1995; 105: 251-254.
68. Lehky TJ, Flerlarge N, Kaz D, Houff S, Hall WH, Ishii K et al. Human T-cell lymphotropic virus type II-associated myelopathy: clinical and immunologic profiles. Ann Neurol 1996; 40: 714-723.
69. Murphy EL, Fridey J, Smith JW, Engstrom J, Sacher RA, Miller K. HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II infected blood donors. Neurology 1997; 48: 315-320.
70. Berger JR, Svenningsson A, Raffanti S, Resnick L. Tropical spastic para paresis-like illness occurring in a patient dually infected with HIV-1 and HTLV-II. Neurology 1991; 41: 85-87,
71. Katz DA, Berger JR. Neurosyphilis in acquired immunodeficiency syndrome. Arch Neurol 1989; 46: 895-898.
72. Berger JR. Spinal cord syphilis associated with human immunodeficiency virus infection: a treatable myelopathy. Am J Med 1992; 92: 101-103.
73. Lanska MJ, Lanska DJ, Schmidley JW. Syphilitic polyradiculopathy in an HIV-positive man. Neurology 1988; 38: 1.297-1.301.
74. Doll DC, Yarbro JW. Mycobacterial spinal cord abcess with an ascending polyneuropathy. Ann Intern Med 1987; 106: 333-334.
75. Woolsey RM, Chambers TJ, Chung HD, McGarry JD. Mycobacterial meningomyelitis associated with human immunodeficiency virus infection Arch Neurol 1988, 45: 691-693.
76. Dromer F, Moulignier A, Dupont B, Guého E, Baudrimont M, Improvisi L et al. Myeloradiculitis due to Cryptococcus curvatus in AIDS. AIDS 1995, 9: 395-396.
77. Mischel PS, Vinters HV. Coccidiomycosis of the central nervous system: neuropathological and vasculopathic manifestations and clinical correlates. Clin Infect Dis 1995; 20: 400-405.
78. Denning DW, Anderson J, Rudge P, Smith H. Acute myelopathy associated with primary infection with human immunodeficiency virus. Br Med J 1987; 294: 143-144.
79. Klein P, Zientek G, Van den Berg SR, Lothman E. Primary CNS lymphoma: lymphomatous meningitis presenting as a cauda equina lesion in an AIDS patient. Can J Neurol Sci 1990; 17: 329-331.
80. Drach LM, Enzensberger W, Fabian T, Herrmann G. Paraneoplasic necrotising myelopathy in a case of AIDS with lymphoma. J Neurol Neurosurg Psychiatry 1996; 60: 237.
81. Kuchelmeister K, Gullota F, Bergmann M, Angeli G, Masini T. Progresive multifocal leukoencephalopathy (PML) in the acquired immunodeficiency syndrome (AIDS). Pathol Res Pract 1993; 189: 163-173.
82. Von Einsiedel RW, Fife TD, Aksamit AJ, Cornford ME, Secor DL, Tomiyasu U et al. Progressive multifocal leukoencephalopathy in AIDS: a clinicopathologic study and review of the literature. J Neurol 1993; 240: 391-406.
83. Bauer W, Chamberlin W, Horenstien S. Spinal demyelination in progressive multifocal leukoencephalopathy. Neurology 1969; 19: 287.
84. Kinloch-de Löes S, Saussure P, Saurat JH, Stalder H, Hirschel B, Perrin LH. Symptomatic primary infection due to human immunodeficiency virus type I: review of 31 cases. Clin Infect Dis 1993; 17: 59-65.
85. Fenelon G, Gray F, Scaravilli F, Mahieux F, Gherardi R, Chemoulli P et al. Ischaemic myelopathy secondary to disseminated intravascular coagulation in AIDS. J Neurol 1991; 238: 51-54.
86. Di Rocco A, Tagliati M, Danisi F, Dorfman D, Moise J, Simpson DM. A pilot study of L-methionine for the treatment of AIDS-associated myelopathy. Neurology 1998; 51: 266-268.